209 related articles for article (PubMed ID: 29050215)
1. Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.
Latosinska A; Mokou M; Makridakis M; Mullen W; Zoidakis J; Lygirou V; Frantzi M; Katafigiotis I; Stravodimos K; Hupe MC; Dobrzynski M; Kolch W; Merseburger AS; Mischak H; Roubelakis MG; Vlahou A
Oncotarget; 2017 Sep; 8(41):69435-69455. PubMed ID: 29050215
[TBL] [Abstract][Full Text] [Related]
2. Lentivirus-mediated knockdown of eukaryotic translation initiation factor 3 subunit D inhibits proliferation of HCT116 colon cancer cells.
Yu X; Zheng B; Chai R
Biosci Rep; 2014 Dec; 34(6):e00161. PubMed ID: 25370813
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway.
Fan Y; Guo Y
Int J Clin Exp Pathol; 2015; 8(9):10420-7. PubMed ID: 26617750
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of eukaryotic translation initiation factor 3 subunit D (eIF3D) inhibits proliferation of acute myeloid leukemia cells.
Liu GZ; Liu JZ; Li XQ; Zhang L; Li SJ; Xiao TW; Wang JX; Li GY; Liu Y
Mol Cell Biochem; 2018 Jan; 438(1-2):191-198. PubMed ID: 28801778
[TBL] [Abstract][Full Text] [Related]
5. Eukaryotic translation initiation factor 3 subunit D overexpression is associated with the occurrence and development of ovarian cancer.
Lin Y; Zhang R; Zhang P
FEBS Open Bio; 2016 Dec; 6(12):1201-1210. PubMed ID: 28203520
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of EIF3D suppresses proliferation of human melanoma cells through G2/M phase arrest.
Li H; Zhou F; Wang H; Lin D; Chen G; Zuo X; Sun L; Zhang X; Yang S
Biotechnol Appl Biochem; 2015; 62(5):615-20. PubMed ID: 25322666
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.
Gao Y; Teng J; Hong Y; Qu F; Ren J; Li L; Pan X; Chen L; Yin L; Xu D; Cui X
Med Oncol; 2015 Jul; 32(7):518. PubMed ID: 26036682
[TBL] [Abstract][Full Text] [Related]
8. EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling.
Pan XW; Chen L; Hong Y; Xu DF; Liu X; Li L; Huang Y; Cui LM; Gan SS; Yang QW; Huang H; Qu FJ; Ye JQ; Wang LH; Cui XG
Int J Oncol; 2016 Jun; 48(6):2580-90. PubMed ID: 27035563
[TBL] [Abstract][Full Text] [Related]
9. OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.
Rose M; Schubert C; Dierichs L; Gaisa NT; Heer M; Heidenreich A; Knüchel R; Dahl E
Epigenetics; 2014 Dec; 9(12):1626-40. PubMed ID: 25625847
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
11. RNAi-Mediated Silencing of EIF3D Alleviates Proliferation and Migration of Glioma U251 and U87MG Cells.
Ren M; Zhou C; Liang H; Wang X; Xu L
Chem Biol Drug Des; 2015 Oct; 86(4):715-22. PubMed ID: 25682860
[TBL] [Abstract][Full Text] [Related]
12. Urinary glycoproteomic profiling of non-muscle invasive and muscle invasive bladder carcinoma patients reveals distinct N-glycosylation pattern of CD44, MGAM, and GINM1.
Sathe G; George IA; Deb B; Jain AP; Patel K; Nayak B; Karmakar S; Seth A; Pandey A; Kumar P
Oncotarget; 2020 Aug; 11(34):3244-3255. PubMed ID: 32922663
[TBL] [Abstract][Full Text] [Related]
13. eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation.
Lee AS; Kranzusch PJ; Doudna JA; Cate JH
Nature; 2016 Aug; 536(7614):96-9. PubMed ID: 27462815
[TBL] [Abstract][Full Text] [Related]
14. Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer.
Fahmy M; Mansure JJ; Brimo F; Yafi FA; Segal R; Althunayan A; Hicks J; Meeker A; Netto G; Kassouf W
Hum Pathol; 2013 Sep; 44(9):1766-72. PubMed ID: 23623586
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer.
Makridakis M; Gagos S; Petrolekas A; Roubelakis MG; Bitsika V; Stravodimos K; Pavlakis K; Anagnou NP; Coleman J; Vlahou A
Proteomics; 2009 Jan; 9(2):287-98. PubMed ID: 19105184
[TBL] [Abstract][Full Text] [Related]
16. EIF3D promoted cervical carcinoma through Warburg effect by interacting with GRP78.
Liu Q; Liu J; Zheng D; Zhang R; Xiang Y; Xu F; Zhou X; Qin J
J Obstet Gynaecol; 2023 Dec; 43(1):2130200. PubMed ID: 36264610
[TBL] [Abstract][Full Text] [Related]
17. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
18. Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity.
Tabaei S; Haghshenas MR; Ariafar A; Gilany K; Stensballe A; Farjadian S; Ghaderi A
Clin Proteomics; 2023 Jul; 20(1):28. PubMed ID: 37501157
[TBL] [Abstract][Full Text] [Related]
19. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cells.
Gai JW; Wahafu W; Song L; Ping H; Wang M; Yang F; Niu Y; Qing W; Xing N
Oncol Lett; 2018 May; 15(5):7631-7638. PubMed ID: 29731899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
